SARA BRAY: Open Payments
NPI 1689256265 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 17 payments from 7 companies in 2025. Trend: 2023 $551 · 2024 $488 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $146 |
| Organon LLC | 3 | $56 |
| Astellas Pharma US Inc | 2 | $53 |
| Sage Therapeutics, LLC | 2 | $39 |
| Exeltis, USA Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
Products named: EVENITY, NEXPLANON, Veozah, ZURZUVAE, SLYND, Qelbree, UNITHROID.
Industry payments across TX — which companies pay providers there.
